Li, Matthew
Khong, Danika
Chin, Ling-Yee
Singleton, Amy
Parekkadan, Biju
Article History
Received: 1 November 2017
Accepted: 21 March 2018
First Online: 1 May 2018
Competing Interests
: B.P. is a founder and equity holder of Sentien Biotechnologies, Inc whom have licensed patents pertaining to MSC therapeutics. The authors declare no other competing interests.